NASDAQ NMS - GLOBAL MARKET · OCS
+2.57% · +$0.3100 · Vol 264.9K
Market closed · last close 4:00 PM ET · price as of 16:00:09 ET
Oculis Holding AG

Oculis Holding AG

Pharmaceuticals
$12.38
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
OCS
Oculis Holding AG
Stale score · Wed Aug 5 · completed session · 32h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Stale score · Wed Aug 5 · completed session · 32h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OCS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OCS catalysts
About Oculis Holding AG
Pharmaceuticals
Listed since
2023
Employees
60
Country
CH

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$11.96
Day high
$12.51
Day low
$11.82
Previous close
$12.07
52W high
$32.65
-62.08% from high
52W low
$10.71
8% of range
Market cap
$728.9M
EPS
$-1.7170
Beta
1.47
Shares out
60.4M
Volume
264.9K
0.70× rel vol
Avg volume
376K
VWAP
$12.28
Price history computed in-house
1W
+9.46%
1M
-9.64%
3M
-62.07%
1Y
-31.98%
YTD
-38.01%
SMA 50 $13.05 · below
SMA 200 $21.82 · below
52W position 8%

OCS overview

Veridion Score
48
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OCS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OCS Form 4 filings
Public disclosures

Congress activity in OCS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OCS in the cached public ledger.

Federal contracts

OCS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OCS in this window.
Lobbying spend

OCS lobbying filings, year to date.

Registered lobbying filings matched to Oculis Holding AG.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OCS in this window.
Loading news for OCS
Analyst ratings
Sovereign unlock shows live analyst consensus for OCS.
Options
Sovereign unlock shows live options positioning for OCS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.